Avalon Trust CO Bristol Myers Squibb CO Transaction History
Avalon Trust CO
- $1.37 Trillion
- Q2 2025
A detailed history of Avalon Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Avalon Trust CO holds 1,846 shares of BMY stock, worth $85,931. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,846
Previous 2,497
26.07%
Holding current value
$85,931
Previous $152 Million
43.89%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,665Shares Held
1.6BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA195MShares$9.07 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.39 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.03 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.41 Billion0.24% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...